Year-end report 2023 – Underlying growth and scaling up the business
2023 has been a dynamic year, concluding a highly active final quarter. This year we achieved record Q2 and Q3 net sales, and now we round up with record Q4 net sales as well. In the last quarter, we released a new innovative X-ray product, participated in the RSNA conference in Chicago, and increased our focus and investments within Point-of-care Ultrasound (POCUS), recognizing its significant growth potential.